The National Institutes of Health intends to award a non-competitive, firm-fixed-price purchase order to Metabolon for high-resolution, untargeted metabolomics analysis using their global metabolomics platform. This analysis will support the National Heart, Lung, and Blood Institute in characterizing neutrophil metabolic profiles from a non-human primate bacterial sepsis model. The acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold. Performance of services will be at Metabolon’s location in Morrisville, North Carolina. No specific timelines or budget amounts are mentioned in the description.